BioLineRx Ltd. Estimated Financial Effect Of Contingent Liabilities
BioLineRx Ltd. (BLRX) had Estimated Financial Effect Of Contingent Liabilities of $3.60 million as of 2021-12-31, per its 20-F filed 2022-03-16.
Discontinued › Notes
ifrs-full:EstimatedFinancialEffectOfContingentLiabilities · last filed 2022-03-16
- 2021-12-31: Estimated Financial Effect Of Contingent Liabilities $3.60M.
- 2020-12-31: Estimated Financial Effect Of Contingent Liabilities $3.50M.
- 2019-12-31: Estimated Financial Effect Of Contingent Liabilities $3.20M.
- 2018-12-31: Estimated Financial Effect Of Contingent Liabilities $3.20M.
| Period end | Estimated Financial Effect Of Contingent Liabilities |
|---|---|
| 2021-12-31 | $3.60M 20-F · filed 2022-03-16 |
| 2020-12-31 | $3.50M 20-F · filed 2021-02-23 |
| 2019-12-31 | $3.20M 20-F · filed 2020-03-12 |
| 2018-12-31 | $3.20M 20-F · filed 2019-03-28 |
| 2017-12-31 | $3.20M 20-F · filed 2018-03-06 |